Evidence map›Paper›PMID 36245905›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2022

United States Food and Drug Administration's authorization of reduced exposure claims for IQOS

Robert Eckford, Gianella Severini, Ernesto M Sebrié, Monique E Muggli, Alexandra Beem, Debra Rosen, Eric Crosbie

Open access · diamondAbstract read
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Overcoming tobacco industry opposition to standardized packaging in the Americas.Revista panamericana de salud publica = Pan American journal of public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Robert EckfordCampaign for Tobacco-Free Kids Washington, DC United States of America Campaign for Tobacco-Free Kids, Washington, DC, United States of America.
Gianella SeveriniCampaign for Tobacco-Free Kids Córdoba Argentina Campaign for Tobacco-Free Kids, Córdoba, Argentina.
Ernesto M SebriéCampaign for Tobacco-Free Kids Washington, DC United States of America Campaign for Tobacco-Free Kids, Washington, DC, United States of America.
Monique E MuggliCampaign for Tobacco-Free Kids Washington, DC United States of America Campaign for Tobacco-Free Kids, Washington, DC, United States of America.
Alexandra BeemCampaign for Tobacco-Free Kids Washington, DC United States of America Campaign for Tobacco-Free Kids, Washington, DC, United States of America.
Debra RosenCampaign for Tobacco-Free Kids Washington, DC United States of America Campaign for Tobacco-Free Kids, Washington, DC, United States of America.
Eric CrosbieSchool of Public Health University of Nevada Reno United States of America School of Public Health, University of Nevada, Reno, United States of America.
Partnership for Drug-Free Kids · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Philip Morris International has used the July 7, 2020 United States Food and Drug Administration's (US FDA) modified risk tobacco product order for IQOS

Indexed as

Latin AmericamarketingpolicyTobacco productsUnited States Food and Drug Administration

Identifiers

PMID36245905
PMCPMC9553011
OpenAlexW4304202812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.